Feasibility Study for the Long-Term Management of Refractory Hyperkeratotic Eczema with Calcipotriol and Betamethasone Dipropionate (Daivobet(®)), Viaminate and Concomitant Conventional Therapies: A Retrospective Study

BACKGROUND: The available treatments for refractory hyperkeratotic eczema are inadequate with frustrating results. We, therefore, incorporated Calcipotriol and Betamethasone Dipropionate (Daivobet(®)), and Viaminate into the mainstay treatment to improve the clinical symptoms. The study aimed to eva...

Descripción completa

Detalles Bibliográficos
Autores principales: Nabatanzi, Amelia, Mafuru, Magesa, Male, Musa, Tian, Chunxia, Zhang, Lingyun, Wu, Ting, Wu, Shidi, Huang, Changzheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7605519/
https://www.ncbi.nlm.nih.gov/pubmed/33149651
http://dx.doi.org/10.2147/CCID.S276148

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7605519/
https://www.ncbi.nlm.nih.gov/pubmed/33149651
http://dx.doi.org/10.2147/CCID.S276148

Ejemplares similares